Erlotinib in the treatment of advanced pancreatic cancer

by Robin K Kelley, Andrew H Ko
Published 2008-03-01

Maintenance Treatment for Metastatic Pancreatic Cancer: Balancing Therapeutic Intensity with Tolerable Toxicity

by Evan J. Walker, Andrew H. Ko
Published 2023-07-01

1361 Neoadjuvant CD40 agonism remodels the tumor immune microenvironment in locally advanced esophageal/gastroesophageal junction cancer

by Li Zhang, Lawrence Fong, Andrew H Ko, Brandon Chen, Alexander Cheung, Alec Starzinski, Hai Yang, Tony Li, Bridget P Keenan, Maira Soto, Erin L Filbert, Stephanie Starzinski, Marissa Gin, Phi Le, Brandon Bol, Frank J Hsu
Published 2023-11-01

765 NG-350A, a tumor-selective anti-CD40 agonist expressing therapeutic, gemcitabine/nab-paclitaxel and ipilimumab for untreated metastatic pancreatic adenocarcinoma: cohort C of t...

by Robert H Vonderheide, Andrew H Ko, Danny Khalil, Oliver Rosen, Robert A Wolff, James Francis, Samantha Bucktrout, Christopher R Cabanski, Silvia Boffo, Zev A Wainberg, Samik Upadhaya, Eileen M O’Reilly, Mark H O’Hara, George Fisher, Jamie Arnott, Ana Rosa Saez-Ibanez, Jay Campbell, Ute Dugan, Jill O’Donnell-Tormey
Published 2023-11-01